{
    "title": "BRIEF-Roche Enters Into Definitive Agreement To Acquire Telavant Including Rights To Novel Tl1a Directed Antibody (Rvt-3101) For The Treatment Of Inflammatory Bowel Disease From Roivant",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12660759/BRIEF-Roche-Enters-Into-Definitive-Agreement-To-Acquire-Telavant-Including-Rights-To-Novel-Tl1a-Directed-Antibody-Rvt-3101-For-The-Treatment-Of-Inflammatory-Bowel-Disease-From-Roivant.html",
    "date": "2023-10-23",
    "keywords": [
        "roche",
        "agreement",
        "antibody",
        "rvt3101",
        "treatment",
        "bowel",
        "disease",
        "ag",
        "purchase",
        "price",
        "payment",
        "option",
        "collaboration",
        "pfizer",
        "nextgeneration",
        "p40tl1a",
        "manufacture",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}